These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 27790945)

  • 21. Nano-vehicles give new lease of life to existing antimicrobials.
    Mela I; Kaminski CF
    Emerg Top Life Sci; 2020 Dec; 4(6):555-566. PubMed ID: 33258900
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Coping with antibiotic resistance: combining nanoparticles with antibiotics and other antimicrobial agents.
    Allahverdiyev AM; Kon KV; Abamor ES; Bagirova M; Rafailovich M
    Expert Rev Anti Infect Ther; 2011 Nov; 9(11):1035-52. PubMed ID: 22029522
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nanomaterials: The New Antimicrobial Magic Bullet.
    Ndayishimiye J; Kumeria T; Popat A; Falconer JR; Blaskovich MAT
    ACS Infect Dis; 2022 Apr; 8(4):693-712. PubMed ID: 35343231
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Broadening the spectrum of small-molecule antibacterials by metallic nanoparticles to overcome microbial resistance.
    Rai M; Ingle AP; Pandit R; Paralikar P; Gupta I; Chaud MV; Dos Santos CA
    Int J Pharm; 2017 Oct; 532(1):139-148. PubMed ID: 28870767
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nano-technology for targeted drug delivery to combat antibiotic resistance.
    Sharma A; Kumar Arya D; Dua M; Chhatwal GS; Johri AK
    Expert Opin Drug Deliv; 2012 Nov; 9(11):1325-32. PubMed ID: 22924701
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Therapeutic strategies to combat antibiotic resistance.
    Brooks BD; Brooks AE
    Adv Drug Deliv Rev; 2014 Nov; 78():14-27. PubMed ID: 25450262
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antibiotic delivery by nanobioceramics.
    Kumar TsS; Madhumathi K
    Ther Deliv; 2016 Aug; 7(8):573-88. PubMed ID: 27444496
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nanomaterials as drug delivery systems with antibacterial properties: current trends and future priorities.
    Khorsandi K; Hosseinzadeh R; Sadat Esfahani H; Keyvani-Ghamsari S; Ur Rahman S
    Expert Rev Anti Infect Ther; 2021 Oct; 19(10):1299-1323. PubMed ID: 33755503
    [No Abstract]   [Full Text] [Related]  

  • 29. The current novel drug delivery system (natural and chemical composites) in dental infections for antibiotics resistance: a narrative review.
    Tahmasebi E; Kaboudanian Ardestani A; Hassani Z; Alam M; Abbasi K; Kahrizi S; Madihi N; Abbasiparashkouh Z; Mohammadi A; Shahab P; Khayatan D; Yazdanian M
    Cell Mol Biol (Noisy-le-grand); 2022 Sep; 68(10):141-160. PubMed ID: 37114257
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Control of biofilm-associated infections by signaling molecules and nanoparticles.
    Holban AM; Gestal MC; Grumezescu AM
    Int J Pharm; 2016 Aug; 510(2):409-18. PubMed ID: 26945736
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lipid and polymer nanoparticles for drug delivery to bacterial biofilms.
    Forier K; Raemdonck K; De Smedt SC; Demeester J; Coenye T; Braeckmans K
    J Control Release; 2014 Sep; 190():607-23. PubMed ID: 24794896
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Promising advances in nanobiotic-based formulations for drug specific targeting against multidrug-resistant microbes and biofilm-associated infections.
    Elfadil D; Elkhatib WF; El-Sayyad GS
    Microb Pathog; 2022 Sep; 170():105721. PubMed ID: 35970290
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-bacterial activity of inorganic nanomaterials and their antimicrobial peptide conjugates against resistant and non-resistant pathogens.
    Pardhi DM; Şen Karaman D; Timonen J; Wu W; Zhang Q; Satija S; Mehta M; Charbe N; McCarron PA; Tambuwala MM; Bakshi HA; Negi P; Aljabali AA; Dua K; Chellappan DK; Behera A; Pathak K; Watharkar RB; Rautio J; Rosenholm JM
    Int J Pharm; 2020 Aug; 586():119531. PubMed ID: 32540348
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nanoparticle-drug conjugates treating bacterial infections.
    Jelinkova P; Mazumdar A; Sur VP; Kociova S; Dolezelikova K; Jimenez AMJ; Koudelkova Z; Mishra PK; Smerkova K; Heger Z; Vaculovicova M; Moulick A; Adam V
    J Control Release; 2019 Aug; 307():166-185. PubMed ID: 31226356
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nanozymes used for antimicrobials and their applications.
    Yang D; Chen Z; Gao Z; Tammina SK; Yang Y
    Colloids Surf B Biointerfaces; 2020 Nov; 195():111252. PubMed ID: 32679446
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nanoparticle approaches against bacterial infections.
    Gao W; Thamphiwatana S; Angsantikul P; Zhang L
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2014; 6(6):532-47. PubMed ID: 25044325
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pulmonary drug delivery: a review on nanocarriers for antibacterial chemotherapy.
    Moreno-Sastre M; Pastor M; Salomon CJ; Esquisabel A; Pedraz JL
    J Antimicrob Chemother; 2015 Nov; 70(11):2945-55. PubMed ID: 26203182
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nanomaterials for the Treatment of Bacterial Biofilms.
    Wang LS; Gupta A; Rotello VM
    ACS Infect Dis; 2016 Jan; 2(1):3-4. PubMed ID: 27622944
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nanomaterials with active targeting as advanced antimicrobials.
    Smerkova K; Dolezelikova K; Bozdechova L; Heger Z; Zurek L; Adam V
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2020 Sep; 12(5):e1636. PubMed ID: 32363802
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bacterial resistance to antibiotics in acute respiratory infections (ARIs).
    López-Antuñano FJ; Silva-Sánchez J
    Arch Med Res; 1997; 28(2):195-203. PubMed ID: 9204608
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.